GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Annexin Pharmaceuticals AB (OSTO:ANNX) » Definitions » Future Policy Benefits

Annexin Pharmaceuticals AB (OSTO:ANNX) Future Policy Benefits


View and export this data going back to 2017. Start your Free Trial

What is Annexin Pharmaceuticals AB Future Policy Benefits?

Future Policy Benefits only applies to insurance companies.


Annexin Pharmaceuticals AB Business Description

Traded in Other Exchanges
N/A
Address
Kammakargatan 48, Stockholm, SWE, 111 60
Annexin Pharmaceuticals AB is a biotechnology company. It is developing biological drug candidate ANXV, a recombinant human protein Annexin A5 for treatment of various cardiovascular diseases. The company also focuses on development of ANXV for the treatment of retinal vein occlusion.